Medtronic (MDT) Tops Q4 EPS by 3c, Offers FY19 Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $82.39 +0.46%
EPS Growth %: +10.3%
Financial Fact:
Cost of products sold: 1.13B
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: +10.3%
Financial Fact:
Cost of products sold: 1.13B
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q4 EPS of $1.42, $0.03 better than the analyst estimate of $1.39. Revenue for the quarter came in at $8.1 billion versus the consensus estimate of $8 billion.
GUIDANCE:
Medtronic sees FY2019 EPS of $5.10-$5.15, versus the consensus of $5.15.
In fiscal year 2019, the company expects organic revenue growth to be in the range of 4.0 to 4.5 percent.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
- Sempra names new CFO and SoCalGas CEO amid infrastructure deal
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
